Yair Lev, MD
Cardiovascular Disease · Philadelphia, PANPI 1346403334
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Novartis at 26.2% of the total. 2025 is the largest year on record at $1,079, 6.5 times the $166 reported in 2019.
Across 126 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$591
- Amgen$431
- Anumana, Inc.$338
- Novo Nordisk$132
- E.r. Squibb & Sons, L.L.C.$103
- Pfizer$98
- plus $562 from 11 others
Across 3 payments — averaging $9165.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$23K
- AstraZeneca$5K
What the payments were for
- Food & beverage$2,255100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 67 | $591 |
| Amgen | 19 | $431 |
| Anumana, Inc. | 2 | $338 |
| Novo Nordisk | 2 | $132 |
| E.r. Squibb & Sons, L.L.C. | 6 | $103 |
| Pfizer | 5 | $98 |
| Atricure, Inc. | 3 | $91 |
| Boehringer Ingelheim | 5 | $88 |
| Johnson & Johnson | 4 | $85 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $72 |
| Impulse Dynamics (USA) Inc. | 2 | $63 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| Heartflow, Inc. | 1 | $38 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
| Philips North America LLC | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ECG-AI LEF$338
- Ozempic$100
- RYBELSUS$100
How this compares
$2,255 in reported general payments places this provider in the 55th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Philadelphia
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Dean KaralisPhiladelphia$385K
- Manavendra BakhshiPhiladelphia$250K
- Philip HainesPhiladelphia$170K
- Julio ChirinosPhiladelphia$145K
- Michael MillerPhiladelphia$133K
- Nehal MehtaPhiladelphia$129K
- Garo GaribianPhiladelphia$115K
- Norman FeinsmithPhiladelphia$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.